Accès ouvert · CC BY

Safety and Feasibility of Autologous Adipose-derived Stromal Vascular Fraction in the Treatment of Keloids: a Phase One Randomised Controlled Pilot Trial

Article scientifique 2021 Sciences de la santé Anglais

Résumé

Abstract Autologous adipose-derived stromal vascular fraction (SVF) is described as a therapeutic alternative in keloid treatment. However, most conclusions are based on observational with the majority conducted in high-income countries and yet the highest-burden of keloids is in Low-and middle-income countries (LMICs). In order to explore the therapeutic benefits of SVF in keloids, the safety and feasibility of their use in LMICs need to be evaluated.Methods: In this phase 1 randomized controlled pilot clinical trial conducted in the Plastic Surgery Unit of Kirruddu National Referral Hospital Kampala, 8 patients were assigned 1:1 ratio into either SVF or Triamcinolone Acetonide (TAC) arms. In the SVF arm, a median (IQR) number of stromal cell infiltration of 2.7x106 (11x106) was administered while the controls received 10mg/ml TAC in a ratio of 1:1 TAC into keloid volume. Primary end-points were adverse events development based on the Common Terminology Criteria for Adverse Events (CTCAE) v5.0 tool and Feasibility assessment based on ≥70% recruitment feasibility and ≥80% interventional feasibility rates. Results: Participant mean age was 27.9 (±6.5) years with a female predilection of 5(63%). Overall, no adverse events were reported in the SVF arm while an ulceration in a single patient in the TAC arm which was a grade II adverse event was reported. Recruitment feasibility of 80% as well as interventional feasibility with 100% completion were reported. Conclusion: Based on our findings, autologous adipose-derived stromal vascular fraction is feasible and safe for the treatment of keloids. Trial registration: ClinicalTrials.gov, NCT04553159. Registered 17th September 2020. Link: https://clinicaltrials.gov/ct2/show/NCT04553159

Citer ce document

Mbiine, R., Kayiira, A., Wayengera, M., Munabi, I. G., Kiwanuka, N., Alenyo, R., Kalanzi, E. W., Muwonge, H., Nakanwagi, C., Joloba, M., & Galukande, M. (2021). Safety and Feasibility of Autologous Adipose-derived Stromal Vascular Fraction in the Treatment of Keloids: a Phase One Randomised Controlled Pilot Trial. Research Square. https://doi.org/10.21203/rs.3.rs-940210/v1

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 05/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 16

Téléchargements (hors robots) : 0

Méthode de comptage